WBC
BSX icon

West Branch Capital’s Boston Scientific BSX Stock Holding History

West Branch Capital’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-6
Closed -$377 – 360
2026
Q1 		$377 Hold
6
– – ﹤0.01% 346
2025
Q4 		$573 Hold
6
– – ﹤0.01% 370
2025
Q3 		$586 Sell
6
-755
-99% -$78.2K ﹤0.01% 398
2025
Q2 		$81.7K Hold
761
– – 0.02% 121
2025
Q1 		$76.8K Buy
761
+755
+12,583% +$76K 0.03% 128
2024
Q4 		$536 Hold
6
– – ﹤0.01% 430
2024
Q3 		$503 Buy
+6
New +$473 ﹤0.01% 419
2024
Q1 		– Sell
-67
Closed -$3.87K – 426
2023
Q4 		$3.87K Buy
+67
New +$3.58K ﹤0.01% 354

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

West Branch Capital's BSX Position: Q2 2026 in Review

West Branch Capital sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 6 shares — an estimated $377 sold.

West Branch Capital first reported a position in BSX in Q4 2023 and held it in 8 quarters. The position peaked at $81.7K in Q2 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • West Branch Capital reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • West Branch Capital sold 6 Boston Scientific shares in Q2 2026, an estimated $377.
  • West Branch Capital first reported a position in Boston Scientific in Q4 2023 and held it in 8 quarters.
  • West Branch Capital's Boston Scientific position peaked at $81.7K in Q2 2025.
  • 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on West Branch Capital's 13F filing for Q2 2026, filed 10 Jul 2026.